Ex vivo phenotyping and potency monitoring of CD19 CAR T cells with a combined flow cytometry and impedance-based real time cell analysis workflow

被引：0
|
作者：
Zhao, Li [1 ]
Lei, Ming [2 ]
Ye, Peifang [2 ]
Lu, Yan [2 ]
Ji, Xiaoping [2 ]
Yan, Yu [2 ]
Jachimowicz, Lauren [1 ]
Guenther, Garret [1 ]
Li, Nancy [1 ]
机构：
[1] Agilent Technol, San Diego, CA USA
[2] Agilent Technol, Hangzhou, Peoples R China
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2145
引用
收藏
页数：2
相关论文
共 44 条
  • [1] OPTIMIZATION OF CAR-T CD19 MONITORING BY FLOW CYTOMETRY AND QUANTITATIVE PCR (Q PCR)
    Garcia-Ortiz, A.
    Rapado, I
    Encinas, J.
    Maroto-Martin, E.
    Sanchez-Pina, J. M.
    Garrido, V
    Moreno Sanz, L.
    Juarez Rufian, A.
    Rufian Vazquez, L.
    Caceres Garcia, M.
    Paciello, M.
    Alonso, R.
    Cedena, T.
    Valeri, A.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2019, 104 : 164 - 164
  • [2] Analysis of CD19.CAR-T cells by flow cytometry and PCR
    Schanda, N.
    Kunz, A.
    Sauer, T.
    Schubert, M. -L
    Korell, F.
    Hueckelhoven-Krauss, A.
    Neuber, B.
    Hinkelbein, M.
    Mueller-Tidow, C.
    Schmitt, M.
    Schmitt, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 259 - 259
  • [3] Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo
    Ye, Xiupeng
    Liu, Meijing
    Lv, Cuicui
    Li, Yeqiong
    Chen, Lan
    Zhang, Jin
    Mu, Juan
    Deng, Qi
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [4] Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow Cytometry
    Kirchmeier, Delaney R.
    Sheih, Alyssa
    Fiorenza, Salvatore
    Hirayama, Alexandre V.
    Chou, Cassie
    Kimble, Erik
    Gauthier, Jordan
    Williams, Alison
    Price, Jason
    Correnti, Colin
    Turtle, Cameron J.
    BLOOD, 2021, 138
  • [5] CD19.CAR-T Cell Analysis Using Flow Cytometry and PCR
    Schanda, Nicola
    Kunz, Alexander
    Sauer, Tim
    Schubert, Maria-Luisa
    Korell, Felix
    Hueckelhoven-Krauss, Angela
    Neuber, Brigitte
    Hinkelbein, Mandy
    Mueller-Tidow, Carsten
    Schmitt, Michael
    Schmitt, Anita
    BLOOD, 2021, 138
  • [6] Single-cell analysis by mass cytometry reveals CD19 CAR T cell spatiotemporal plasticity in patients
    Goldberg, Lior
    Haas, Eric R.
    Vyas, Vibhuti
    Urak, Ryan
    Forman, Stephen J.
    Wang, Xiuli
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [7] Single-Cell Analysis By Mass Cytometry Reveals CD19 CAR T Cell Spatiotemporal Plasticity in Patients
    Goldberg, Lior
    Haas, Eric R.
    Vyas, Vibhuti
    Urak, Ryan
    Forman, Stephen J.
    Wang, Xiuli
    BLOOD, 2021, 138
  • [8] Functional T Cell Assays Are Predictive of Pre-Clinical Potency to Generate Allogeneic, Hypoimmune CD19 CAR T Cells
    Salloum, Darin
    Tundwal, Kavita
    Kangeyan, Divy
    Johnson, Adam
    van Hoeven, Neal
    Granger, Brian
    Moreno, Jesus
    Liang, Ouwen
    Beauchesne, Pascal
    Fry, Terry J.
    Foster, Aaron
    BLOOD, 2022, 140 : 4524 - 4525
  • [9] γδT cell-meciated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay
    Seidel, Ursula Joerdis Eva
    Vogt, Fabian
    Grosse-Hovest, Ludger
    Jung, Gundram
    Handgretinger, Rupert
    Lang, Peter
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [10] Combining CD19 CAR T cells with T cell-engaging bispecific antibody treatment enhances efficacy in murine models of CLL and ex vivo patient cultures
    Floerchinger, Alessia
    Brinkmann, Berit J.
    Roider, Tobias
    Bruch, Peter-Martin
    Angeli, Antonia
    Ohl, Sibylle
    Mack, Norman
    Coelho, Mariana
    Roessner, Philipp M.
    Dietrich, Sascha
    Seiffert, Martina
    LEUKEMIA & LYMPHOMA, 2023, 64 : S195 - S196
12345